These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 16394064)

  • 1. Use of the levonorgestrel-releasing intrauterine system and breast cancer.
    Tjalma WA; Trinh XB; van Dam PA
    Obstet Gynecol; 2006 Jan; 107(1):207-8; author reply 208. PubMed ID: 16394064
    [No Abstract]   [Full Text] [Related]  

  • 2. Levonorgestrel-releasing and copper intrauterine devices and the risk of breast cancer.
    Dinger J; Bardenheuer K; Minh TD
    Contraception; 2011 Mar; 83(3):211-7. PubMed ID: 21310281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of the levonorgestrel-releasing intrauterine system and breast cancer.
    Backman T; Rauramo I; Jaakkola K; Inki P; Vaahtera K; Launonen A; Koskenvuo M
    Obstet Gynecol; 2005 Oct; 106(4):813-7. PubMed ID: 16199640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levonorgestrel-releasing intra-uterine systems (LNG-IUS) and breast cancer.
    Neven P; Amant F; Poppe W; Van den Broecke R
    Fertil Steril; 2009 Apr; 91(4):e5; author reply e6. PubMed ID: 19249759
    [No Abstract]   [Full Text] [Related]  

  • 5. [Levonorgestrel-releasing intrauterine device (Mirena) and breast cancer: what do we learn from literature for clinical practice?].
    Boutet G
    Gynecol Obstet Fertil; 2006 Nov; 34(11):1015-23. PubMed ID: 17092752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of the levonorgestrel-releasing intrauterine system in breast cancer patients.
    Trinh XB; Tjalma WA; Makar AP; Buytaert G; Weyler J; van Dam PA
    Fertil Steril; 2008 Jul; 90(1):17-22. PubMed ID: 17706209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term effects of the levonorgestrel-releasing intrauterine system on serum lipids and the endometrium in breast cancer patients taking tamoxifen.
    Kesim MD; Aydin Y; Atis A; Mandiraci G
    Climacteric; 2008 Jun; 11(3):252-7. PubMed ID: 18568790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of the levonorgestrel-releasing intrauterine system on the resistance to activated protein C (APC).
    van Vliet HA; Tchaikovski SN; Rosendaal FR; Rosing J; Helmerhorst FM
    Thromb Haemost; 2009 Apr; 101(4):691-5. PubMed ID: 19350113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Releasing Intrauterine System of Levonorgestrel and risk for breast cancer. ].
    Scapinelli A; Oliveira VM; Takagi MM; Aldrighi JM
    Rev Assoc Med Bras (1992); 2010; 56(6):636-7. PubMed ID: 21271125
    [No Abstract]   [Full Text] [Related]  

  • 10. Levonorgestrel-releasing intrauterine device and uterine perforations.
    Prescrire Int; 2007 Dec; 16(92):248-9. PubMed ID: 18092420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. von Willebrand's disease diagnosed after menorrhagia worsened from levonorgestrel intrauterine system.
    Lukes AS; Perry S; Ortel TL
    Obstet Gynecol; 2005 May; 105(5 Pt 2):1223-6. PubMed ID: 15863590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Connection between levonorgestrel-IUD and GAS (Group A Streptococcus) sepsis? Reliable risk assessment is not yet possible].
    Milsom I; Landgren BM; Alestig K
    Lakartidningen; 1995 Dec; 92(50):4781-2. PubMed ID: 8538290
    [No Abstract]   [Full Text] [Related]  

  • 13. Uterine perforation in women using a levonorgestrel-releasing intrauterine system.
    Van Houdenhoven K; van Kaam KJ; van Grootheest AC; Salemans TH; Dunselman GA
    Contraception; 2006 Mar; 73(3):257-60. PubMed ID: 16472566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [One year experience of levonorgestrel-releasing intrauterine device].
    Lähteenmäki P; Shain RN; Ratsula K; Toivonen J; Holden AE; Rosenthal M; Luukkainen T
    Duodecim; 1991; 107(1):26-31. PubMed ID: 1364704
    [No Abstract]   [Full Text] [Related]  

  • 15. Hair loss with use of the levonorgestrel intrauterine device.
    Paterson H; Clifton J; Miller D; Ashton J; Harrison-Woolrych M
    Contraception; 2007 Oct; 76(4):306-9. PubMed ID: 17900442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two cases of abortion and premature birth after removal of a levonorgestrel-releasing intrauterine system.
    Rollnik JD; Lück HJ; Giersig C
    Eur J Contracept Reprod Health Care; 2002 Dec; 7(4):244-6. PubMed ID: 12648298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer risk in women using the levonorgestrel-releasing intrauterine system in Finland.
    Soini T; Hurskainen R; Grénman S; Mäenpää J; Paavonen J; Pukkala E
    Obstet Gynecol; 2014 Aug; 124(2 Pt 1):292-299. PubMed ID: 25004338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levonorgestrel-releasing intrauterine system and new-onset acne.
    Ilse JR; Greenberg HL; Bennett DD
    Cutis; 2008 Aug; 82(2):158. PubMed ID: 18792549
    [No Abstract]   [Full Text] [Related]  

  • 19. Hypertension and use of an intrauterine levonorgestrel-releasing device.
    Vos AG; van de Ree MA
    Neth J Med; 2012 Nov; 70(9):431. PubMed ID: 23123543
    [No Abstract]   [Full Text] [Related]  

  • 20. Intrauterine contraception: an update.
    Bhathena RK; Guillebaud J
    J Obstet Gynaecol; 2008 Apr; 28(3):262-5. PubMed ID: 18569464
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.